PPARG and Alzheimer disease: Beside the ameliorating effect of PPARγ agonists on the inflammatory status of the AD brain by repressing the secretion of proinflammatory molecules and the enhancement of mitochondrial function, a direct involvement in the processing of the Aβ peptide has been demonstrated Fig. (1).